WallStSmart

Cardinal Health Inc (CAH)vsSynergy CHC Corp. Common Stock (SNYR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cardinal Health Inc generates 707317% more annual revenue ($244.67B vs $34.59M). SNYR leads profitability with a 7.5% profit margin vs 0.7%. SNYR trades at a lower P/E of 4.2x. CAH earns a higher WallStSmart Score of 53/100 (C-).

CAH

Buy

53

out of 100

Grade: C-

Growth: 7.3Profit: 4.5Value: 8.7Quality: 5.8
Piotroski: 4/9Altman Z: 4.30

SNYR

Hold

45

out of 100

Grade: D

Growth: 4.3Profit: 6.0Value: 7.0Quality: 7.0
Piotroski: 4/9Altman Z: -0.45
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CAHUndervalued (+14.8%)

Margin of Safety

+14.8%

Fair Value

$263.37

Current Price

$211.31

$52.06 discount

UndervaluedFair: $263.37Overvalued
SNYRUndervalued (+13.2%)

Margin of Safety

+13.2%

Fair Value

$1.90

Current Price

$1.17

$0.73 discount

UndervaluedFair: $1.90Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CAH2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
4.3010/10

Safe zone — low bankruptcy risk

Revenue GrowthGrowth
18.8%8/10

18.8% revenue growth

SNYR2 strengths · Avg: 10.0/10
P/E RatioValuation
4.2x10/10

Attractively priced relative to earnings

Debt/EquityHealth
-3.0410/10

Conservative balance sheet, low leverage

Areas to Watch

CAH4 concerns · Avg: 3.3/10
P/E RatioValuation
29.8x4/10

Moderate valuation

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Profit MarginProfitability
0.7%3/10

0.7% margin — thin

Operating MarginProfitability
1.2%3/10

Operating margin of 1.2%

SNYR4 concerns · Avg: 2.5/10
Market CapQuality
$13.16M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
7.5%3/10

7.5% margin — thin

Return on EquityProfitability
-3.6%2/10

ROE of -3.6% — below average capital efficiency

EPS GrowthGrowth
-90.6%2/10

Earnings declined 90.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : CAH

The strongest argument for CAH centers on Altman Z-Score, Revenue Growth. Revenue growth of 18.8% demonstrates continued momentum. PEG of 1.33 suggests the stock is reasonably priced for its growth.

Bull Case : SNYR

The strongest argument for SNYR centers on P/E Ratio, Debt/Equity. Revenue growth of 12.4% demonstrates continued momentum.

Bear Case : CAH

The primary concerns for CAH are P/E Ratio, Return on Equity, Profit Margin. Thin 0.7% margins leave little buffer for downturns.

Bear Case : SNYR

The primary concerns for SNYR are Market Cap, Profit Margin, Return on Equity.

Key Dynamics to Monitor

CAH profiles as a growth stock while SNYR is a value play — different risk/reward profiles.

SNYR carries more volatility with a beta of 1.27 — expect wider price swings.

CAH is growing revenue faster at 18.8% — sustainability is the question.

CAH generates stronger free cash flow (555M), providing more financial flexibility.

Bottom Line

CAH scores higher overall (53/100 vs 45/100) and 18.8% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cardinal Health Inc

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Cardinal Health, Inc. is an American multinational health care services company.

Visit Website →

Synergy CHC Corp. Common Stock

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Synergy CHC Corp. The company is headquartered in Westbrook, Maine.

Want to dig deeper into these stocks?